Used in cancer research as an intermediate in the synthesis of taxol derivatives, which exhibit potent antitumor activity. It serves as a key compound for developing novel chemotherapy agents, particularly in modifying the taxane core to enhance drug solubility, reduce resistance, and improve selectivity toward cancer cells. Its xylosyl group allows for targeted prodrug strategies and enzyme-triggered activation in tumor environments. Also employed in structure-activity relationship studies to optimize anticancer efficacy within the taxol family.